Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets optimized for use with the Gyrolab platform New reagent set effectively detects host cell impurities from HEK 293 cells used in vaccine and viral vector manufacturing for cell and gene therapies, and vaccines Uppsala, Sweden: Gyros Protein Technologies (part of Mesa Labs’ Biopharmaceutical Development […]

Center will develop new technologies and reproducible analytical techniques to support rapid, cost-effective clinical research into applications for metabolomics in precision medicine SAN JOSE, Calif. and DAVIS, Calif. — Thermo Fisher Scientific, (NYSE: TMO) the world leader in serving science, and the University of California, Davis (UC Davis) West Coast Metabolomics Center today announced The […]

TOKYO – PHC Corporation (headquarters: Minato-ku, Tokyo, President: Kyoji Morimoto, hereafter PHC) has today announced the launch of the DNBSEQTM Series of the next-generation DNA sequencers (product models: DNBSEQ-T7, DNBSEQ-G400, DNBSEQ-G50)*1. This follows the signing of an agreement with MGI Tech Co., Ltd. (headquarters: Shenzhen, China, President: Mu Feng, hereafter MGI) for the sales rights in […]

Horizon Discovery is proud to announce that we are collaborating with YCharOS, Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, as members of YCharOS’s newly formed Industry Advisory Committee (IAC). The role of the IAC is to support YCharOS in realizing its purpose to enable users […]

VectorBuilder – a global leader in vector design, optimization and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production. VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production […]

Risk-sharing alliance on tailor-made phenotypic models for IBD and HBV Upfront payment and milestone payments for MIMETAS Access to know-how on novel disease models and assays for Roche Option to exclusively license of disease models and assays for Roche LEIDEN, The Netherlands — MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading pharmaceutical […]

SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) announced significant progress in China with the adoption of its Saphyr® System for optical genome mapping (OGM) by WeHealth Shanghai, a leading provider of genome analysis services in reproductive health. The adoption was announced at the Structural Variation Symposium in Shanghai, organized with support from the Shanghai […]

Chicago/Boston — GE Healthcare and SOPHiA GENETICS today announced that they have signed a letter of intent to collaborate on advancing cancer care, with the goal of better targeting and matching treatments to each patient’s genomic profile and cancer type, helping to ensure the most effective and personalized treatment. The companies aim to develop new artificial intelligence (AI)-powered […]

License agreement to enhance Nippon Gene’s CRISPR/Cas9 research reagents offering Dublin, Ireland and Tokyo, Japan, 01 July 2021: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents […]

Shoreline Biome’s microbiome products now available in the Nordics FARMINGTON, Conn.— Shoreline Biome, a leading microbiome company that develops complete solutions for characterizing microbiome populations down to the strain level, has entered into a partnership with AH diagnostics A/S for product distribution.  Shoreline Biome’s complete suite of products for use on the industry leading next […]